Acquisition of 1,500,000 units of ibuprofen oral solid 400 mg box x blister/strip; 40,000 units of ibuprofen oral liquid 200 mg/5 ML box x bottle x 100 ML (minimum) with dispenser; and 27,000 units of ketorolac parenteral liquid 30 mg/ML box x ampoule(s) x 1 ML medications belonging to therapeutic group m (musculoskeletal system) for the medical units of the M. I. Mu

The Municipality of Guayaquil, under process code SIE-MIMG-2025-113-44856, is seeking to acquire significant quantities of Ibuprofen and Ketorolac medications for its medical units. The required items include 1,500,000 units of Ibuprofen solid oral tablets (400 mg, blister packs), 40,000 units of Ibuprofen liquid oral suspension (200 mg/5 ml, 100 ml bottle with a dispenser), and 27,000 units of Ketorolac liquid parenteral solution (30 mg/ml, 1 ml ampoules). These medications fall under therapeutic group M (Musculoskeletal System). The estimated value for the Ketorolac component is USD 80,130.00. The procurement method is an Electronic Reverse Auction. This procurement is vital for equipping the Municipality's healthcare facilities with essential pain relief and anti-inflammatory medications, ensuring that patients receive timely and appropriate treatment for various conditions managed by the musculoskeletal system.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.